METROPOLIS HEALTHCARE IPO is a chain of diagnostic companies and is all set to make a debut in the stock market with an issue size of 1204.29 Cr.
METROPOLIS HEALTHCARE IPO – Overview
| Issue Date | 3-5 April 2019 |
| IPO Opening Date | 3 April 2019 |
| IPO Face Value | INR 2 per share |
| IPO Price | INR 880 per share |
| IPO Lot Size | 17 Shares |
| Issue Size | 1346 Cr |
| Offer for sale | – |
| Issue Type | Book built Issue IPO |
| Listing At | BSE, NSE |
| QIB Shares Offered | 8.88 times |
| NII (HNI) Shares | 3.03 times |
| Company Promoters | Promoters of the company are: 1. Dr Sushil Kanubhai Shah 2. Ameera Sushil Shah 3. Metz Advisory LLP |
METROPOLIS HEALTHCARE IPO -Tentative Dates
| IPO opening date | 3 April 2019 |
| IPO closing date | 5 April 2019 |
| Basis of Allotment | 10 April 2019 |
| Initiation of Refunds | 11 April 2019 |
| The credit of Shares to Demat | 12 April 2019 |
| IPO Listing Date | 15 April 2019 |
Industry Overview.
The Indian diagnostic industry is estimated to grow at a CAGR of approximately 16.5% to approximately ₹ 596 billion (USD 9.1 billion) in the financial year 2018. For the next two years, India’s diagnostic industry is expected to grow at a CAGR of approximately 16% to reach approximately ₹ 802 billion (USD 12.3 billion) in the financial year 2020.
METROPOLIS HEALTHCARE IPO- Company Overview
Metropolis Healthcare Limited is a chain of diagnostic companies. It has 106 clinical laboratories and 1130 collection centers in seven countries. In India, it has laboratories across 18 states and 173 cities for monitoring of disease, early detection, and diagnostic screening.
The company also provides analytical and support services for clinical research projects to some clinical research organizations. In the last financial year (2018), approximately 7.7 million patients visited the lab and around 16.0 million tests conducted in the clinics.
METROPOLIS HEALTHCARE IPO-Objectives
- Listing of Equity Shares will enhance the visibility and brand image of the company.
- Provide a public market for the Equity Shares in India.
METROPOLIS HEALTHCARE IPO- Financial Statements
| Particulars | 31-Dec -18 | 31-Mar-18 | 31-Mar-17 |
| Total Assets | 5,838.75 | 5,303.40 | 5,151.59 |
| Total Revenue | 5,593.06 | 6,435.67 | 5,447.24 |
| Profit After Tax | 887.71 | 1,097.47 | 1,072.57 |
METROPOLIS HEALTHCARE IPO- Strengths
- Well positioned for expected industry growth.
- Widespread operational network.
- Comprehensive test menu.
- Focus on quality and customer service.
- Robust information technology structure.
Company Contact Information
Metropolis Healthcare Limited
250 D Udyog Bhavan,
Hind Cycle Marg, Worli
Mumbai 400 030, Maharashtra
Phone: (91 22) 6258 2810
Email: investor.relations@metropolisindia.com
Website: https://www.metropolisindia.com/
Metropolis IPO Registrar
Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: metropolis.ipo@linkintime.co.in
Website: https://linkintime.co.in/
